Anti-SARS-CoV-2 Nucleocapsid Antibody, Human IgG1 is isolated from a SARS-CoV-2 infected patient and is recombinantly produced from human 293 cells (HEK293).
Conjugation:
Unconjugated
Alternative Names:
2019 peak N Protein, 2019-nCoV N, 2019-nCoV N Protein, 2019-nCoV Nucleoprotein, 2019-nCoV nucleocapsid protein., 2019nCoV N, SARS-CoV-2 NP, SARS-CoV-2 Nucleocapsid Protein, novel coronavirus N Protein, novel coronavirus Nucleocapsid Protein, nucleocapsid
Lyophilized from 0.22 im filtered solution in PBS, pH7.4 . Normally trehalose is added as protectant before lyophilization.
Form:
Lyophilized
Application Dilute:
Optimal dilutions for each application to be determined by the researcher.
Application Notes:
This antibody can be paired with other Anti-SARS-CoV-2 Nucleocapsid antibodies to detect SARS-CoV-2 Nucleocapsid protein in sandwich ELISA or LFA assay.
* VAT and and shipping costs not included. Errors and price changes excepted